Smartphone app for depression alongside standard treatments
Part of Mental health clinical trials.
This study tests a smartphone app called Rejoyn, which is designed to help people with depression, when used alongside their usual treatment (like antidepressants, TMS, or esketamine). The goal is to see how well the app works in real life to improve depression symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of major depression
- You are currently taking an antidepressant
- You are getting or starting TMS (a magnetic brain therapy) or esketamine (a nasal spray) at this clinic
- If getting TMS, you can start the app within the first two weeks of TMS
- You have mild or more severe depression symptoms (based on a standard questionnaire)
- You have access to a compatible smartphone and can read English
- Your doctor agrees the app is a good fit for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital program (smartphone app or website) to help people with tough-to-treat depression. If you are already receiving advanced treatments like rTMS, ketamine, or ECT at St. Michael's Hospital, you may be able to join and see if this extra digital support improves your mood.
This study tests a smartphone-based emotional monitoring device (EMOCARE) to see if it can accurately measure your mood compared to a standard depression questionnaire. It may help researchers find a simpler way to track depression symptoms.
This trial tests a smartphone app called Kandoo to help make a type of talk therapy called behavioral activation more effective for reducing depression symptoms. It aims to help teens and young adults feel better by encouraging them to re-engage in positive activities.
This study tests a smartphone app called Moodivate that helps treat depression through your regular doctor's office using video visits. It's designed for people with mild-to-moderate depression who want a flexible, technology-based treatment option.
This study tests a smartphone app that sends you helpful messages throughout the day to support your mood. It is designed for teens with depression symptoms who are seen in primary care, and could help you feel better day by day.
This trial tests a smartphone app that helps doctors manage depression in everyday life. It may help improve how care is tracked and adjusted soon after starting antidepressant treatment.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.